• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 72610.0
  • ISIN : INE338H01029
1,662.90 -18 (-1.05%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    1,649.00

  • Today’s High

    1,690.45

  • Open

    1,655.40

  • Perv Close

    1,680.60

  • 52W Low

    1,327.05

  • 52W High

    2,664.00

Key Indicators

  • P/E(TTM)

    52.88

  • Mar.Cap (₹Cr.)

    17,396.63

  • Div & Yield %

    0.53

  • Book Value(₹)

    152.04

  • Debt-Equity Ratio

    -1.05

  • AGM Date

    01-Apr-2025

  • EPS

    31.38

  • P/E Ratio

    52.88

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    17,396.63

  • RONW (%)

    21.88

  • ROCE (%)

    29.05

Score Board

  • Equity (₹ in Cr.)

    10.46

  • BV (₹)

    152.00

  • Sales( ₹ in Cr.)

    1,016.94

  • NP (in Cr.)

    294.25

  • NP Var(%)

    25.0

  • Div%

    875.0

  • CPS (₹)

    33.20

  • EPS (₹)

    28.10

  • Traded Value (₹ in Lakhs)

    17,360.54

  • 52 Week High

    2,664.00

  • 52 Week Low

    1,327.05

  • Price BSE

    1659.0

  • Price NSE

    1,663.00

  • Market Capital( in Cr.)

    17,360.54

  • P/C Ratio

    49.90

  • P/E Ratio

    59.00

  • Price Vs.BV

    28.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,016.94 853.17 712.93 616.94 512.33 436.01
Excise Duty 995.33 828.35 703.99 602.42 498.18 427.15
Net Sales 1,016.94 853.17 712.93 616.94 512.33 436.01
Other Income 33.78 35.31 23.42 13.81 31.37 17.44
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,050.72 888.48 736.35 630.75 543.70 453.45
EXPENDITURE :
Raw Materials 995.33 828.35 703.99 602.42 498.18 427.15
Power & Fuel Cost 995.33 828.35 703.99 602.42 498.18 427.15
Employee Cost 123.05 110.28 95.69 69.47 62.24 51.82
Other Manufacturing Expenses 9.09 13.88 23.31 10.64 16.12 2.43
Selling & Administrative Expenses 91.08 82.93 67.90 44.87 32.27 32.05
Miscellaneous Expenses 9.09 13.88 23.31 10.64 16.12 2.43
Less : Pre-operative Expenses Capitalised :
Total Expenditure 641.53 568.42 495.19 317.58 330.21 275.53
Operating Profit 132.97 122.59 88.74 52.85 67.70 61.21
Interest 2.55 4.51 5.48 0.67 0.70 0.69
Gross Profit 409.19 320.05 241.16 313.17 213.49 177.92
Depreciation 53.59 54.03 50.05 27.52 21.25 19.31
Profit Before Tax 409.19 320.05 241.16 313.17 213.49 177.92
Tax 99.83 79.53 58.49 75.72 54.47 55.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.63 2.38 3.71 2.34 -10.00 3.91
Reported Net Profit 304.73 238.13 178.57 235.33 168.96 118.39
Extraordinary Items 409.19 320.05 241.16 313.17 213.49 177.92
Adjusted Net Profit 304.73 238.13 178.57 235.33 168.96 118.39
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 91.54 71.45 4.87 0.00 37.33 0.00
P & L Balance carried down 304.73 238.13 178.57 235.33 168.96 118.39
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 875.00 683.00 51.20 0.00 392.50 0.00
Dividend Per Share(Rs) 8.75 6.83 5.12 0.00 39.25 0.00
Earnings Per Share-Unit Curr 29.13 22.76 17.07 22.50 177.66 124.48
Book Value 91.54 71.45 4.87 0.00 37.33 0.00
Book Value(Adj)-Unit Curr 91.54 71.45 4.87 0.00 37.33 0.00

Shareholding Pattern

  • Promoter Group

    44.08%

  • Public Share Holding

    55.92%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,752,000 4.54 4,752,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,364,356 39.54 41,364,356 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 46,116,356 44.08 46,116,356 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,718,348 8.33 8,718,348 90
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,372,576 4.18 4,372,576 7
Mutual Funds / UTI 5,088,943 4.86 5,088,943 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 643,966 0.62 643,966 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,823,833 17.99 18,823,833 126
2] Non Institution
Bodies Corporate 1,809,192 1.73 1,809,192 553
Clearing Members 36,567 0.04 36,567 2
Directors of their Relatives 210,000 0.20 210,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 2,092,325 2.00 2,092,325 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,307,360 2.21 2,307,360 1,023
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 216,659 0.21 216,659 2,552
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,571,991 1.50 1,571,991 1
Individuals holding nominal share capital up to Rs. 1 lakh 6,100,590 5.83 6,100,590 77,732
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,314,531 24.20 25,314,531 6
Others 16,800 0.02 16,800 1
Sub Total 39,676,015 37.93 39,676,015 81,872
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 104,616,204 100.00 104,616,204 82,004

Company Background

Concord Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Biotech Ltd
  • BSE Code : 72610.0
  • ISIN : INE338H01029

  • Incorporation Year

    1984

  • Registered Office

    1482-86 Trasad Road
    Dholka, Ahmedabad,
    Gujarat-382225

  • Telephone

    91-079-68138700

  • FAX

  • Chairman

    SUDHIR JAIRAM VAID

  • Managing Director

    SUDHIR JAIRAM VAID

  • Company Secretary

    S Prakash

  • Auditor

    Deloitte Haskins & Sells/BSR & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Concord Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Biotech 1,659.45 1,050.72 1,016.94 52.88 28.81
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92